Widow Hopes For Answers After Husband’s Death

A Kibworth woman whose husband died from a ‘rare reaction’ to a Covid vaccine is hoping for answers from the latest phase of the public inquiry into the pandemic.

Neil Miller developed fatal blood clotting after having an AstraZeneca jab in March 2021 and died less than two months later, aged 50.

His widow, Kam Miller is part of the Vaccine Injured and Bereaved UK (VIBUK) campaign group, which is giving evidence as the UK Covid-19 Inquiry looks at issues relating to the development of vaccines and the implementation of the roll-out programme.

Kam travelled to London with other members of the group, as their representative gave evidence at the inquiry.

Kam Miller (left) holding a picture of Neil outside the Covid 19 Inquiry

The group is campaigning for adequate compensation for the families of those affected and transparency over the vaccine roll-out.

Kam, who says she is not ‘anti-vaccination’, spoke to HFM:

Neil Miller

Speaking at the hearing, Hugo Keith KC, counsel to the inquiry, said expert evidence commissioned by the inquiry suggested ‘overwhelmingly’ that the UK operated ‘a robust and sophisticated system’ for ensuring the highest levels of safety.

He added: “The evidence suggests overwhelmingly that the UK Covid vaccines successfully protected the people of the UK against a virus that was killing and liable to kill hundreds of thousands of people.

“Side-effects may be encountered in any medicine, but serious side-effects, whilst very rare, are nevertheless significant and debilitating.

“For those who did suffer serious side-effects, and even worse, for the very small number of people whose loved ones died as a result, it was, of course, a complete tragedy, and nothing that is said about the rarity of those terrible consequences can be taken, or should be taken, to diminish that loss.”

A spokesperson for AstraZeneca previously  told HFM: “Patient safety is our highest priority and regulatory authorities have clear and stringent standards to ensure the safe use of all medicines, including vaccines.

“Our sympathy goes out to anyone who has lost loved ones or reported health problems.

“From the body of evidence in clinical trials and real-world data, the AstraZeneca-Oxford vaccine has continuously been shown to have an acceptable safety profile and regulators around the world consistently state that the benefits of vaccination outweigh the risks of extremely rare potential side effects.

“The Medicines and Healthcare products Regulatory Authority (MHRA) has granted full marketing approval for the vaccine based on its safety profile and efficacy.

“Over 3 billion doses of the vaccine have been supplied to more than 180 countries and, according to independent estimates, the AstraZeneca-Oxford vaccine helped to save more than six million lives worldwide in the first year of availability alone.”